Series A funding round for Enveda Biosciences raising $51M in June 2021
Series A funding round for Enveda Biosciences raising $51M in June 2021
| Investor | Firm Type | Partner |
|---|
Lux CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Matthew De Silva |
| Angel | Henry Kravis |
| Angel | rajiv chegu |
| Angel | Jonathan Milner |
| Angel | Chris Gibson |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $51M in a Series A round.
The round was announced on 06/01/21.
The round was led by Zavain Dar.